James V Cassella - Net Worth and Insider Trading
James V Cassella Net Worth
The estimated net worth of James V Cassella is at least $1 Million dollars as of 2024-04-25. James V Cassella is the Chief Development Officer of Concert Pharmaceuticals Inc and owns about 176,823 shares of Concert Pharmaceuticals Inc (CNCE) stock worth over $1 Million. Details can be seen in James V Cassella's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that James V Cassella has not made any transactions after 2023-01-30 and currently still holds the listed stock(s).
Transaction Summary of James V Cassella
James V Cassella Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James V Cassella owns 3 companies in total, including Concert Pharmaceuticals Inc (CNCE) , Trevi Therapeutics Inc (TRVI) , and Alexza Pharmaceuticals Inc (ALXA) .
Click here to see the complete history of James V Cassella’s form 4 insider trades.
Insider Ownership Summary of James V Cassella
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
CNCE | Concert Pharmaceuticals Inc | 2023-01-30 | Chief Development Officer |
TRVI | Trevi Therapeutics Inc | 2020-02-13 | director |
ALXA | Alexza Pharmaceuticals Inc | 2015-01-23 | director & Former EVP & R&D and CSO |
James V Cassella Latest Holdings Summary
James V Cassella currently owns a total of 1 stock. James V Cassella owns 176,823 shares of Concert Pharmaceuticals Inc (CNCE) as of January 30, 2023, with a value of $1 Million.
Latest Holdings of James V Cassella
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
CNCE | Concert Pharmaceuticals Inc | 2023-01-30 | 176,823 | 8.37 | 1,480,009 |
Holding Weightings of James V Cassella
James V Cassella Form 4 Trading Tracker
According to the SEC Form 4 filings, James V Cassella has made a total of 6 transactions in Concert Pharmaceuticals Inc (CNCE) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Concert Pharmaceuticals Inc is the sale of 10,106 shares on January 30, 2023, which brought James V Cassella around $84,385.
Insider Trading History of James V Cassella
- 1
James V Cassella Trading Performance
James V Cassella Ownership Network
Ownership Network List of James V Cassella
Ownership Network Relation of James V Cassella
James V Cassella Owned Company Details
What does Concert Pharmaceuticals Inc do?
Who are the key executives at Concert Pharmaceuticals Inc?
James V Cassella is the Chief Development Officer of Concert Pharmaceuticals Inc. Other key executives at Concert Pharmaceuticals Inc include CFO & PFO Marc A. Becker , Chief Operating Officer Nancy Stuart , and Chief Legal Officer Jeffrey A Munsie .
Concert Pharmaceuticals Inc (CNCE) Insider Trades Summary
Over the past 18 months, James V Cassella made 2 insider transaction in Concert Pharmaceuticals Inc (CNCE) with a net sale of 12,999. Other recent insider transactions involving Concert Pharmaceuticals Inc (CNCE) include a net sale of 16,093 shares made by Nancy Stuart , a net sale of 11,386 shares made by Jeffrey A Munsie , and a net sale of 11,386 shares made by Marc A. Becker .
In summary, during the past 3 months, insiders sold 0 shares of Concert Pharmaceuticals Inc (CNCE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 61,104 shares of Concert Pharmaceuticals Inc (CNCE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 61,104 shares.
Concert Pharmaceuticals Inc (CNCE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Concert Pharmaceuticals Inc Insider Transactions
James V Cassella Mailing Address
Above is the net worth, insider trading, and ownership report for James V Cassella. You might contact James V Cassella via mailing address: 2091 Stierlin Court, Mountain View Ca 94043.